Innovation1 Biotech Inc Quick Ratio (MYYZ) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Innovation1 Biotech Inc   (MYYZ)

Innovation1 Biotech Inc 's Quick Ratio

MYYZ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Innovation1 Biotech Inc 's Cash & cash equivalent grew by 1747.86 % in the Q2 2024 sequentially, faster than Current Liabilities, this led to improvement in Innovation1 Biotech Inc 's Quick Ratio to 0.04, Quick Ratio remained below Innovation1 Biotech Inc average.

Within Major Pharmaceutical Preparations industry 482 other companies have achieved higher Quick Ratio than Innovation1 Biotech Inc in second quarter 2024. While Quick Ratio total ranking has improved so far during the Q2 2024 to 4377, from total ranking in the first quarter 2023 at 4788.

Explain Quick Ratio?
How much Cash & cash equivalents MYYZ´s has?
What are MYYZ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYYZ Quick Ratio (Feb 29 2024)
Q2		 (Nov 30 2023)
Q1		 (Aug 31 2023)
Q4		 (May 31 2023)
Q3		 (Feb 28 2023)
Q2
Y / Y Current Liabilities Change 24.36 % 38.76 % -88.97 % -91.55 % -92.02 %
Y / Y Cash & cash equivalent Change -59.03 % -97.37 % - -69.83 % -80.85 %
Quick Ratio MRQ 0.04 0 - 0.08 0.11
MYYZ's Total Ranking # 4377 # 4788 # 0 # 3963 # 3753
Seq. Current Liabilities Change 9.34 % -19.2 % 31.8 % 6.81 % 22 %
Seq. Cash & cash equivalent Change 1747.86 % - - -19.99 % 18.63 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 483
Healthcare Sector # 977
Overall Market # 4377


Quick Ratio Statistics
High Average Low
6.1 0.4 0
(Aug 31 2017)   (Nov 30 2023)




Financial Statements
Innovation1 Biotech Inc 's Current Liabilities $ 3 Millions Visit MYYZ's Balance sheet
Innovation1 Biotech Inc 's Cash & cash equivalent $ 0 Millions Visit MYYZ's Balance sheet
Source of MYYZ's Sales Visit MYYZ's Sales by Geography


Cumulative Innovation1 Biotech Inc 's Quick Ratio

MYYZ's Quick Ratio for the trailling 12 Months

MYYZ Quick Ratio

 (Feb 29 2024)
12 Months		 (Nov 30 2023)
12 Months		 (Aug 31 2023)
12 Months		 (May 31 2023)
12 Months		 (Feb 28 2023)
12 Months
Y / Y Current Liabilities TTM Growth -82.16 % -88.1 % -91.5 % -58.71 % 7.56 %
Y / Y Cash & cash equivalent TTM Growth -79.09 % -81.98 % -87.07 % -79.36 % -65.43 %
Quick Ratio TTM 0.03 0.04 0.07 0.03 0.02
Total Ranking TTM # 3825 # 4055 # 3820 # 4061 # 3967
Seq. Current Liabilities TTM Growth 5.28 % 7.4 % -72.56 % -42.51 % -29.76 %
Seq. Cash & cash equivalent TTM Growth -32.4 % -31.05 % -34.57 % -31.44 % -41.74 %

Quick ratio ranking by company, industry and sector >> Back to MYYZ Financial Strength Comparisons >> Go to Compare MYYZ Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2024 to $2.90 millions, cumulative Quick Ratio decreased to 0.03 below the Innovation1 Biotech Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 492 other companies have achieved higher Quick Ratio than Innovation1 Biotech Inc . While Quick Ratio overall ranking has improved so far to 3825, from total ranking during the twelve months ending first quarter 2023 at 4055.

Explain Quick Ratio?
How much Cash & cash equivalents MYYZ´s has?
What are MYYZ´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 493
Healthcare Sector # 1020
Within the Market # 3825


trailing twelve months Quick Ratio Statistics
High Average Low
0.89 0.17 0.01
(Aug 31 2018)   (Feb 28 2021)




Companies with similar Quick Ratio in the quarter ending Feb 29 2024, within Major Pharmaceutical Preparations Industry Quick RatioFeb 29 2024 MRQ Cash & cash equivalentFeb 29 2024 MRQ Current Liabilities
Aeon Biopharma inc   0.10 $ 1.558  Millions$ 15.957  Millions
Takeda Pharmaceutical Company Limited  0.10 $ 3,331.420  Millions$ 34,209.302  Millions
NIKA PHARMACEUTICALS, INC  0.09 $ 0.025  Millions$ 0.266  Millions
Mustang Bio inc   0.09 $ 1.337  Millions$ 15.691  Millions
Lifecore Biomedical Inc   0.08 $ 3.073  Millions$ 36.810  Millions
Dr Reddy s Laboratories Limited  0.07 $ 85.000  Millions$ 1,152.000  Millions
One World Products Inc   0.06 $ 0.126  Millions$ 1.971  Millions
Kazia Therapeutics Limited  0.06 $ 1.106  Millions$ 17.648  Millions
Amneal Pharmaceuticals Inc   0.06 $ 51.617  Millions$ 834.388  Millions
Prophase Labs Inc   0.05 $ 1.233  Millions$ 23.907  Millions
Intelgenx Technologies Corp   0.05 $ 0.846  Millions$ 16.516  Millions
Bio path Holdings inc   0.05 $ 0.188  Millions$ 3.812  Millions
Protokinetix Incorporated  0.04 $ 0.003  Millions$ 0.068  Millions
Northwest Biotherapeutics Inc  0.04 $ 2.478  Millions$ 62.440  Millions
Innovation1 Biotech Inc   0.04 $ 0.108  Millions$ 2.904  Millions
Nexien Biopharma Inc   0.03 $ 0.010  Millions$ 0.340  Millions
Celularity Inc   0.03 $ 1.902  Millions$ 66.044  Millions
Abvc Biopharma Inc   0.03 $ 0.167  Millions$ 6.028  Millions
Emmaus Life Sciences Inc   0.03 $ 1.712  Millions$ 62.428  Millions
Panbela Therapeutics Inc   0.02 $ 0.262  Millions$ 10.519  Millions
Cnbx Pharmaceuticals Inc   0.02 $ 0.037  Millions$ 1.524  Millions
Pmgc Holdings Inc   0.02 $ 0.029  Millions$ 1.222  Millions
Allarity Therapeutics Inc   0.02 $ 0.312  Millions$ 18.008  Millions
Regen Biopharma Inc   0.02 $ 0.078  Millions$ 5.173  Millions
Lunai Bioworks Inc   0.01 $ 0.313  Millions$ 20.874  Millions
Seelos Therapeutics inc   0.01 $ 0.524  Millions$ 36.716  Millions
Kaya Holdings Inc   0.01 $ 0.075  Millions$ 6.257  Millions
Citius Oncology Inc  0.01 $ 0.033  Millions$ 2.819  Millions
Oncotelic Therapeutics Inc   0.01 $ 0.189  Millions$ 16.512  Millions
Bespoke Extracts Inc  0.01 $ 0.014  Millions$ 1.281  Millions

Date modified: 2026-09-08T15:11:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.